Vetoquinol - Universal Registration Document - 2021

1 PRESENTATION OF THE GROUP Vetoquinol, your trusted animal health partner Vetoquinol Universal Registration Document 2020 Financial report 9 • Vetoquinol enters the digital arena by acquiring a majority stake in Farmvet Systems Ltd, based in Northern Ireland. • Vetoquinol continues the industrial upgrading program at the Lure site, via the Aucapi project (3 rd year). • Vetoquinol acquires a new R&D center in France and expands its innovation capacity. • Launch of two pet products: Sonotix and Flexadin Chews. • First MA obtained for the Japanese joint venture: Cefaseptin. • Vetoquinol ranked 2 nd in the 2018 Gaia Index. • Vetoquinol to acquire rights for Profender ® and Drontal ® from Elanco Animal Health for the European Economic Area and the UK. • Vetoquinol adapts its structure and work tools to deal with the COVID-19 global health crisis. • Vetoquinol purchases a 90% equity stake in Clarion Biociencias, a veterinary drug manufacturer based in Goias state, Brazil. • Launch of two pet products in the USA: Ph-Notix and Flexprofen. • Establishment of a subsidiary in New Zealand: Vetoquinol New Zealand Ltd. • Vetoquinol acquires two reproduction products destined for the Australian and New Zealand markets: Cattle-Mate and Ovu-Late. • Vetoquinol announces the reorganization of its industrial facilities in Italy, Poland and France (VITAL project). • Vetoquinol et Klox Technologies Limited, a subsidiary of Klox Technologies Inc., enter into an exclusive global licensing agreement excluding China. Under the agreement, Vetoquinol will develop and market Klox’s fluorescent light energy (FLE) products in the domain of animal health. 2019 2020 2018